Use of SGLT2 inhibitors vs GLP-1 RAs and anemia in patients with diabetes and CKD
Hu JC, Shao SC, Tsai DH, et al.
JAMA Netw Open. 2024;7(3):e240946.
Leggi
Hu JC, Shao SC, Tsai DH, et al.
JAMA Netw Open. 2024;7(3):e240946.
Leggi
Giorgino F, Guja C, Aydın H, et al.
Diabetes Res Clin Pract. 2024;111604.
Leggi
Nôga DA, Meth EMES, Pacheco AP, et al.
JAMA Netw Open. 2024;7(3):e241147.
Leggi
Marfella R, Prattichizzo F, Sardu C, et al.
N Engl J Med. 2024;390(10):900-910.
Leggi
Giorda CB, Picariello R, Tartaglino B, et al.
Diabetes Res Clin Pract. 2024;111603.
Leggi
Bergman M, Manco M, Satman I, et al.
Diabetes Res Clin Pract. 2024;111589.
Leggi
Quirós C, Herrera MT, Amigó J, et al.
Diabetes Technol Ther. Pub. online 28 Feb 2024.
Leggi
Rauscher FG, Elze T, Francke M, et al.
Diabetologia. Pub. online 2 Mar 2024.
Leggi
Jang SA, Kim KM, Kang HJ, et al.
Diabetes Res Clin Pract 2024;111601.
Leggi
Mesquita LA, Spiazzi BF, Piccoli GF, et al.
Diabetes Obes Metab. Pub. online 23 Feb 2024.
Leggi